| Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non … KK Jørgensen, IC Olsen, GL Goll, M Lorentzen, N Bolstad, ... The Lancet 389 (10086), 2304-2316, 2017 | 911 | 2017 |
| A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry B Glintborg, IJ Sørensen, AG Loft, H Lindegaard, A Linauskas, ... Annals of the rheumatic diseases 76 (8), 1426-1431, 2017 | 248 | 2017 |
| To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with … B Glintborg, AG Loft, E Omerovic, O Hendricks, A Linauskas, J Espesen, ... Annals of the rheumatic diseases 78 (2), 192-200, 2019 | 176 | 2019 |
| Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial GL Goll, KK Jørgensen, J Sexton, IC Olsen, N Bolstad, EA Haavardsholm, ... Journal of internal medicine 285 (6), 653-669, 2019 | 116 | 2019 |
| Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE … MA D'Agostino, RJ Wakefield, H Berner-Hammer, O Vittecoq, G Filippou, ... Annals of the rheumatic diseases 75 (10), 1763-1769, 2016 | 111 | 2016 |
| Public relations and emerging functions of the public sphere: An analytical framework I Jensen Journal of communication management 6 (2), 133-147, 2002 | 86 | 2002 |
| Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO … B Glintborg, P Højgaard, M Lund Hetland, N Steen Krogh, G Kollerup, ... Rheumatology 55 (4), 659-668, 2016 | 84 | 2016 |
| Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients. B Pedersen, IM Jensen Leukemia 5 (7), 566-573, 1991 | 83 | 1991 |
| Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry EH Ibfelt, J Sørensen, DV Jensen, L Dreyer, B Schiøttz-Christensen, ... Clinical epidemiology, 627-632, 2017 | 71 | 2017 |
| Occupationally related respiratory symptoms in trout‐processing workers D Sherson, I Hansen, T Sigsgaard Allergy 44 (5), 336-341, 1989 | 67 | 1989 |
| Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics … TS Jørgensen, LE Kristensen, R Christensen, H Bliddal, T Lorenzen, ... Rheumatology 54 (12), 2156-2165, 2015 | 60 | 2015 |
| Desferrioxamine treatment reduces blood transfusion requirements in patients with myelodysplastic syndrome PD Jensen, IM Jensen, J Ellegaard British Journal of Haematology 80 (1), 121-124, 1992 | 60 | 1992 |
| Ankylosing spondylitis versus nonradiographic axial spondyloarthritis: comparison of tumor necrosis factor inhibitor effectiveness and effect of HLA-B27 status. An … B Glintborg, IJ Sørensen, M Østergaard, L Dreyer, AA Mohamoud, ... The Journal of Rheumatology 44 (1), 59-69, 2017 | 55 | 2017 |
| Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study L Dreyer, RL Cordtz, IMJ Hansen, LE Kristensen, ML Hetland, ... Annals of the Rheumatic Diseases 77 (4), 510-514, 2018 | 48 | 2018 |
| Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C … A Emamifar, J Hangaard, IMJ Hansen Medicine 96 (43), e8357, 2017 | 43 | 2017 |
| The reliability of disease activity score in 28 joints–C-reactive protein might be overestimated in a subgroup of rheumatoid arthritis patients, when the score is solely based … IMJ Hansen, RA Andreasen, MN van Bui Hansen, A Emamifar JCR: Journal of Clinical Rheumatology 23 (2), 102-106, 2017 | 41 | 2017 |
| Is hearing impairment associated with rheumatoid arthritis? a review A Emamifar, K Bjoerndal, IMJ Hansen The open rheumatology journal 10, 26, 2016 | 41 | 2016 |
| Legitimacy and strategy of different companies: A perspective of external and internal public relations I Jensen Public relations research: An international perspective, 1997 | 33 | 1997 |
| Occupational asthma caused by sodium disulphite in Norwegian lobster fishing J Madsen, D Sherson, H Kjøller, I Hansen, K Rasmussen Occupational and environmental medicine 61 (10), 873-874, 2004 | 30 | 2004 |
| Public relations and the public sphere in the future I Jensen 7th International Public Relations Research Symposium, Bled, Slovenia, 2000 | 28 | 2000 |
Amir EmamifarDepartment of Rheumatology, Rigshospital GlostrupΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα regionh.dk
